Grufity logo
Grufity logo

Latest Privium Fund Management B.V. Stock Portfolio

$544Million | No. of Holdings #61

Privium Fund Management B.V. Performance

2026 Q2+15.92%
YTD-0.19%
2025+33.11%

About Privium Fund Management B.V. and 13F Hedge Fund Stock Holdings

On 2026-08-07, the fund reported it's updated stock portfolio. In the 13F Holdings report, Privium Fund Management B.V. reported an equity portfolio of $544.2 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Privium Fund Management B.V. are TSLA, SHOP, AMD. The fund has invested 17.6% of it's portfolio in TESLA INC and 7.8% of portfolio in SHOPIFY INC. <br><br> The fund managers got completely rid off COINBASE GLOBAL INC (COIN), SEA LTD (SE) and ESPERION THERAPEUTICS INC NE (ESPR) stocks. They significantly reduced their stock positions in MOLINA HEALTHCARE INC (MOH), 4D MOLECULAR THERAPEUTICS IN (FDMT) and ARROWHEAD PHARMACEUTICALS IN (ARWR). Privium Fund Management B.V. opened new stock positions in OPENDOOR TECHNOLOGIES INC (OPEN), CEREBRAS SYSTEMS INC and ZOETIS INC (ZTS). The fund showed a lot of confidence in some stocks as they added substantially to SAREPTA THERAPEUTICS INC (SRPT), B2GOLD CORP (BTG) and HIMS & HERS HEALTH INC (HIMS).
Privium Fund Management B.V. Equity Portfolio Value
Last Reported on: 07 Aug, 2026
$544Million
  as of Aug 07, 2026

Privium Fund Management B.V. Annual Return Estimates Vs S&P 500

Our best estimate is that Privium Fund Management B.V. made a return of 15.92% in the last quarter. In trailing 12 months, it's portfolio return was 21%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
opendoor technologies inc18,207,000
cerebras systems inc13,370,500
space exploration techn corp6,834,400
magnum ice cream co nv1,496,500
zoetis inc1,244,760
legend biotech corp1,022,350
totalenergies se729,486
nu hldgs ltd587,840
New stocks bought by Privium Fund Management B.V.

Additions

Ticker% Inc.
sarepta therapeutics inc196
b2gold corp102
hims & hers health inc100
tidewater inc new58.36
transocean ltd36.58
arcutis biotherapeutics inc24.42
amazon com inc12.00
biontech se11.48
Additions to existing portfolio by Privium Fund Management B.V.

Reductions

Ticker% Reduced
molina healthcare inc-63.4
4d molecular therapeutics in-47.07
arrowhead pharmaceuticals in-36.17
uniqure nv-32.52
axsome therapeutics inc.-31.99
lexeo therapeutics inc-24.39
biomarin pharmaceutical inc-18.75
spotify technology s a-17.91
Privium Fund Management B.V. reduced stake in above stock

Sold off

Ticker$ Sold
esperion therapeutics inc ne-9,040,470
engene holdings inc-2,397,710
sea ltd-11,427,800
coinbase global inc-13,794,200
pfizer inc-1,479,230
stoke therapeutics inc-1,628,000
seabridge gold inc-703,626
slb limited-948,197
Privium Fund Management B.V. got rid off the above stocks

Sector Distribution

Privium Fund Management B.V. has about 29.3% of it's holdings in Healthcare sector.

  • Healthcare
  • Consumer Cyclical
  • Others
  • Technology
  • Communication Services
  • Real Estate
  • Financial Services
Sector%
Healthcare29.3
Consumer Cyclical23.9
Others18.4
Technology16.3
Communication Services4.6
Real Estate3.3
Financial Services3.2

Market Cap. Distribution

Privium Fund Management B.V. has about 51.5% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MEGA-CAP
  • UNALLOCATED
  • MID-CAP
  • LARGE-CAP
  • SMALL-CAP
Category%
MEGA-CAP37.6
UNALLOCATED23.1
MID-CAP21.5
LARGE-CAP13.9
SMALL-CAP3.3

Stocks belong to which Index?

About 59.6% of the stocks held by Privium Fund Management B.V. either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • S&P 500
  • RUSSELL 2000
Index%
Others40.4
S&P 50037
RUSSELL 200022.6
Top 5 Winners (%)%
AMD
advanced micro devices inc
185.6 %
QURE
uniqure nv
152.2 %
FATE
fate therapeutics inc
125.0 %
URGN
urogen pharma ltd
98.5 %
SELB
cartesian therapeutics inc
64.1 %
Top 5 Winners ($)$
AMD
advanced micro devices inc
23.4 M
QURE
uniqure nv
12.1 M
TSLA
tesla inc
11.0 M
ARWR
arrowhead pharmaceuticals in
5.7 M
RARE
ultragenyx pharmaceutical in
4.4 M
Top 5 Losers (%)%
RIG
transocean ltd
-23.6 %
PLTR
palantir technologies inc
-20.2 %
WVE
wave life sciences ltd
-19.9 %
TDW
tidewater inc new
-17.2 %
lexeo therapeutics inc
-16.5 %
Top 5 Losers ($)$
PLTR
palantir technologies inc
-5.9 M
SHOP
shopify inc
-1.7 M
SPOT
spotify technology s a
-1.6 M
ALNY
alnylam pharmaceuticals inc
-0.4 M
WVE
wave life sciences ltd
-0.3 M

Privium Fund Management B.V. Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Privium Fund Management B.V.

Privium Fund Management B.V. has 61 stocks in it's portfolio. About 61.8% of the portfolio is in top 10 stocks. PLTR proved to be the most loss making stock for the portfolio. AMD was the most profitable stock for Privium Fund Management B.V. last quarter.

$544.22MTotal Value
72.00Positions
07 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Privium Fund Management B.V., last reported on 07 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ABEV
Ambev Sa

Ambev Sa

ABEV
Privium Fund Management B.V.'s holding in Ambev Sa over time
0.46%802,167
$2.52M
0.46%
decreased 15.43 percentreduced
AUTL
Autolus Therapeutics Ltd

Autolus Therapeutics Ltd

AUTL
Privium Fund Management B.V.'s holding in Autolus Therapeutics Ltd over time
0.11%363,430
$581.5K
0.11%
unchanged 0 percentunchanged
BNTX
Biontech Se

Biontech Se

BNTX
Privium Fund Management B.V.'s holding in Biontech Se over time
0.52%30,100
$2.80M
0.52%
increased 11.48 percentadded
BTG
B2gold Corp

B2gold Corp

BTG
Privium Fund Management B.V.'s holding in B2gold Corp over time
0.13%195,083
$729.6K
0.13%
increased 102.21 percentadded
CSAN
Cosan S A

Cosan S A

CSAN
Privium Fund Management B.V.'s holding in Cosan S A over time
0.03%52,000
$149.8K
0.03%
new position